COST-MINIMIZATION ANALYSIS OF DELAFLOXACIN VERSUS STANDARD OF CARE FOR THE TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS (ABSSSI) IN JORDAN

被引：0
|
作者：
Naser, A. [1 ]
Bilbisi, M. [2 ]
Mousa, R. [3 ]
机构：
[1] Isra Univ, Amman, Jordan
[2] Abdali Med Ctr, Amman, Jordan
[3] Univ Jordan, Fac Pharm, Amman, Jordan
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 12期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE636
引用
收藏
页码：S175 / S175
页数：1
相关论文
共 50 条
  • [1] Delafloxacin meglumine for the treatment of acute bacterial skin and skin structure infections (ABSSSI)
    Kaul, G.
    Kapoor, E.
    Dasgupta, A.
    Chopra, S.
    DRUGS OF TODAY, 2018, 54 (11) : 657 - 666
  • [2] COST MINIMIZATION ANALYSIS OF TEDIZOLID FOR THE TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN SUB-STRUCTURE INFECTIONS (ABSSSI) IN GREECE
    Insinga, R.
    Dalakaki, E.
    Retsa, M. P.
    Karokis, A.
    Sarpong, E. M.
    VALUE IN HEALTH, 2016, 19 (07) : A417 - A417
  • [3] Delafloxacin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
    Lee, Young Ran
    Burton, Caitlin Elizabeth
    Bevel, Kolton Rucks
    JOURNAL OF PHARMACY TECHNOLOGY, 2019, 35 (03) : 110 - 118
  • [4] A cost-minimization analysis of dalbavancin compared to conventional therapy for the outpatient treatment of acute bacterial skin and skin-structure infections
    Turco, Neil J.
    Kane-Gill, Sandra L.
    Hernandez, Inmaculada
    Oleksiuk, Louise-Marie
    D'Amico, Frank
    Pickering, Aaron J.
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (04) : 319 - 325
  • [5] Delafloxacin in Acute Bacterial Skin and Skin Structure Infections
    Corey, G. Ralph
    McKinnell, Jamie A.
    Rybak, Michael J.
    CLINICAL INFECTIOUS DISEASES, 2019, 68 : S191 - S192
  • [6] Cost analysis of dalbavancin versus standard of care for the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in two Italian hospitals
    Bai, Francesca
    Mazzitelli, Maria
    Silvola, Sofia
    Raumer, Francesca
    Restelli, Umberto
    Croce, Davide
    Marchetti, Giulia
    Cattelan, Anna Maria
    JAC-ANTIMICROBIAL RESISTANCE, 2023, 5 (02):
  • [7] A COMPARATIVE COST ANALYSIS BETWEEN DALBAVANCIN, ORITAVANCIN AND DELAFLOXACIN FOR THE TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS IN SPAIN
    Rios, M.
    Carcedo, D.
    Sabaniego, J.
    Rossello, I
    VALUE IN HEALTH, 2023, 26 (12) : S86 - S86
  • [8] Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
    Scott, L. J.
    DRUGS, 2020, 80 (12) : 1247 - 1258
  • [9] Delafloxacin: A Review in Acute Bacterial Skin and Skin Structure Infections
    L. J. Scott
    Drugs, 2020, 80 : 1247 - 1258
  • [10] Clinical efficacy of dalbavancin for the treatment of acute bacterial skin and skin structure infections (ABSSSI)
    Leuthner, Kimberly D.
    Buechler, Kristin A.
    Kogan, David
    Saguros, Agafe
    Lee, H. Stephen
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2016, 12 : 931 - 940
12345